Generic drug giant Mylan reported that first-quarter profits skidded 75 percent to $13.9 million from $56.6 million a year earlier on higher expenses.
Per-share profits fell 77 percent to 3 cents from 13 cents.
Meanwhile, the company named a new chief financial officer Tuesday to replace the retired CFO.
On an adjusted basis, earnings per share rose 9 percent to 76 cents, in line with Wall Street estimates. Adjusted figures excluded special items, chiefly amortization expenses related to acquisitions completed in 2015.
Revenue for the quarter climbed 17 percent to $2.19 billion from $1.87 billion.
“We are off to a great start in 2016,” CEO Heather Bresch said in a statement, reaffirming the company’s full-year adjusted earnings guidance of $4.85 to $5.15 per share.
Mylan announced in February it was buying Swedish specialty drug company Meda AB for $9.9 billion in cash, stock and the assumption of debt. The deal came on the heels of a failed, protracted attempt to buy Perrigo Co., an Irish over-the-counter drug specialist, for about $26 billion.
Meda on Tuesday reported that sales and profits for the first quarter sank below year-ago levels. The weak results were expected, Ms. Bresch told analysts in a mid-morning conference call, adding that Mylan remained committed to completing the acquisition by the end of the third quarter.
“We are committed a billion percent to bringing the Meda asset in,” she said. “As we’ve always said, it’s not what the company’s doing on a standalone basis. It’s what we’re going to do as a combined platform.”
Mylan, which reincorporated in the Netherlands but is run from executive offices in Cecil, said Kenneth Parks would be its new CFO, replacing the retired John Sheehan. The appointment is effective June 6.
Mr. Parks is senior vice president and CFO at Station Square-based Wesco International, a distributor of electrical, industrial and other products. He spent the majority of his career at United Technologies Corp. in a variety of U.S. and international finance roles.
Mylan shares added 98 cents Tuesday, or 2.29 percent, to close at $43.69.
Patricia Sabatini: PSabatini@post-gazette.com or 412-263-3066.
Patricia Sabatini: PSabatini@post-gazette.com or 412-263-3066.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.